{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:42:15Z","timestamp":1790347335976,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ijantimicag.2013.01.018","type":"journal-article","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T06:45:33Z","timestamp":1362552333000},"page":"564-568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?"],"prefix":"10.1016","volume":"41","author":[{"given":"Andrew A.","family":"Udy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Covajes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Silvio","family":"Taccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lipman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00134-004-2157-0","article-title":"Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units","volume":"30","author":"Finfer","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0010","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008","volume":"36","author":"Dellinger","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0015","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/CCM.0b013e3181961bff","article-title":"Pharmacokinetic issues for antibiotics in the critically ill patient","volume":"37","author":"Roberts","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0020","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.ccx.0000247448.94252.5a","article-title":"The epidemiology of acute renal failure in the world","volume":"12","author":"Uchino","year":"2006","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0025","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1097\/00003246-200209000-00016","article-title":"Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients","volume":"30","author":"Metnitz","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0030","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/ndt\/gfm610","article-title":"Acute renal failure in patients with severe sepsis and septic shock\u2014a significant independent risk factor for mortality: results from the German Prevalence Study","volume":"23","author":"Oppert","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0035","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.2174\/138920111798808275","article-title":"Dosing of antibiotics in critically ill patients undergoing renal replacement therapy","volume":"12","author":"Kielstein","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0040","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1097\/CCM.0b013e318241e553","article-title":"Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study","volume":"40","author":"Roberts","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0045","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1097\/CCM.0b013e3181aab3d0","article-title":"Principles of antibacterial dosing in continuous renal replacement therapy","volume":"37","author":"Choi","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0050","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijantimicag.2011.05.013","article-title":"Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study","volume":"38","author":"Hanberger","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/0310057X0903700320","article-title":"Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study","volume":"37","author":"Ho","year":"2009","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0060","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/600877","article-title":"Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists","volume":"49","author":"Rybak","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0065","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1128\/AAC.32.6.848","article-title":"Vancomycin pharmacokinetics in patients with various degrees of renal function","volume":"32","author":"Rodvold","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0070","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1128\/AAC.01708-10","article-title":"Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens","volume":"55","author":"Roberts","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0075","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijantimicag.2011.04.010","article-title":"Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients","volume":"38","author":"Chaijamorn","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0080","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1128\/AAC.00459-12","article-title":"Effect of continuous venovenous hemofiltration dose on achievement of adequate vancomycin trough concentrations","volume":"56","author":"Frazee","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0085","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijantimicag.2012.10.018","article-title":"Continuous infusion of vancomycin in septic patients on continuous renal replacement therapy","volume":"41","author":"Covajes","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0090","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00134-003-1662-x","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference","volume":"29","author":"Levy","year":"2003","journal-title":"Intensive Care Med"},{"issue":"4 Suppl.","key":"10.1016\/j.ijantimicag.2013.01.018_bib0095","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1097\/CCM.0b013e318168e3fb","article-title":"Indications and timing of renal replacement therapy in acute kidney injury","volume":"36","author":"Palevsky","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0100","series-title":"NONMEM user guides (I\u2013VIII)","author":"Beal","year":"1998"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2125.2004.02143.x","article-title":"Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration","volume":"58","author":"DelDot","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0110","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa0902413","article-title":"Intensity of continuous renal-replacement therapy in critically ill patients","volume":"361","author":"Bellomo","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0115","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/clpt.1991.208","article-title":"Vancomycin pharmacokinetics in acute renal failure: preservation of nonrenal clearance","volume":"50","author":"Macias","year":"1991","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0120","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/cc10061","article-title":"A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis","volume":"15","author":"Karvellas","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0125","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00134-003-1672-8","article-title":"Continuous is not continuous: the incidence and impact of circuit \u2018down-time\u2019 on uraemic control during continuous veno-venous haemofiltration","volume":"29","author":"Uchino","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2013.01.018_bib0130","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijantimicag.2009.08.005","article-title":"Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections","volume":"34","author":"Berthoin","year":"2009","journal-title":"Int J Antimicrob Agents"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913000459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913000459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T14:23:47Z","timestamp":1562768627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857913000459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0924857913000459"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.01.018","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}